Balance Sheet for Actinium Pharmaceuticals Inc. (Delaware) (ATNM)

$ 0.2359   0.0059 (+2.57%) Volume: 312.43k 8:00 PM EDT 13-Sep-2019
After Hours:  $ 0.2358   -0.0001 (-0.04%) Volume: 1.02k 5:40 PM EDT 13-Sep-2019
Statement: View:
Assets [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Cash and Equivalents 13,673 17,400 20,519 25,643 6,707
Restrictable Cash 40 - 35 35 -
Marketable Securities - - - - 11
Accounts Receivable - - - - -
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables - - - - -
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 616 439 1,836 803 689
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 14,330 17,839 22,390 26,481 7,407
Land and Improvements - - - - -
Buildings and Improvement - - - - -
Machinery, Furniture and Equipment 385 273 259 199 167
Construction in Progress - - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 385 273 259 199 167
Gross Fixed Assets 385 273 259 199 167
Accumulated Depreciation (266) (216) (170) (93) (39)
Net Fixed Assets 119 57 89 106 128
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 391 391 - - 35
Total Non-Current Assets 560 498 138 106 162
Total Assets 14,889 18,337 22,529 26,588 7,569
Liabilities [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Accounts Payable 5,814 4,650 4,220 1,499 2,498
Short Term Debt - - 268 - -
Notes Payable 249 - - 266 284
Accrued Expenses - - - - -
Accrued Liabilities - - - - -
Deferred Revenues - - - - -
Current Deferred Income Taxes - - - - -
Other Current Liabilities - 16 33 2,849 6,710
Total Current Liabilities 6,063 4,666 4,521 4,614 9,492
Long Term Debt 13 - - - -
Deferred Income Tax - - - - -
Other Non-Current Liabilities - - - - -
Minority Interest - - - - -
Capital Lease Obligations 13 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 13 - - - -
Total Liabilities 6,077 4,666 4,521 4,614 9,492
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 8,813 13,671 18,008 21,974 (1,923)
Common Par 116 80 56 44 30
Additional Paid in Capital 195,554 176,744 154,504 134,160 89,252
Cumulative Translation Adjustments - - - - -
Retained Earnings (186,857) (163,153) (136,552) (112,230) (91,205)
Treasury Stock - - - - -
Other Equity Adjustments - - - - -
Total Capitalization 8,813 13,671 18,008 21,974 (1,923)
Total Equity 8,813 13,671 18,008 21,974 (1,923)
Total Liabilities & Shareholder's Equity 14,889 18,337 22,529 26,588 7,569
Cash Flow (23,654) (26,601) (24,322) (21,025) (24,688)
Working Capital 8,266 13,173 17,870 21,868 (2,085)
Free Cash Flow (20,667) (21,578) (20,849) (18,592) (14,500)
Invested Capital 8,813 13,671 18,008 21,974 (1,923)
Shares Outstanding - Common Class Only 115,703 80,072 55,802 44,067 29,972
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 115,703 80,072 55,802 44,067 29,972
Total Common Shares Outstanding 115,703 80,072 55,802 44,067 29,972
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 106,042 66,746 48,463 38,158 27,364
Diluted Weighted Shares Outstanding 106,042 66,746 48,463 38,158 27,364